Details of the Drug

General Information of Drug (ID: DM7WGPW)

• Drug Name: Wharton's Jelly-Mesenchymal Stem Cells
• Synonyms: WJ-MSCs

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D00HDZ

References

• [1] ClinicalTrials.gov (NCT04313322) Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells. U.S. National Institutes of Health.